Segment Data and Regional Results
Half-Year Financial Report 2024
Segment data Q2/H1 — Chemicals
| Q2 | H1 | |||||
Million € |
2024 | 2023 | +/- | 2024 | 2023 | +/- |
| Sales to third parties | 2,838 | 2,679 | 6.0% | 5,603 | 5,512 | 1.6% |
of which Petrochemicals |
2,144 | 1,930 | 11.1% | 4,150 | 3,920 | 5.8% |
Intermediates |
695 | 750 | –7.3% | 1,453 | 1,592 | –8.7% |
EBITDA before special items |
444 | 393 | 13.0% | 896 | 819 | 9.4% |
| EBITDA |
443 | 399 | 10.9% | 896 | 825 | 8.7% |
| EBITDA margin before special items (%) |
15.6 | 14.7 | − | 16.0 | 14.9 | − |
| Depreciation and amortizationa | 213 | 187 | 14.3% | 413 | 372 | 11.1% |
| Income from operations (EBIT) | 230 | 213 | 8.0% | 483 | 453 | 6.7% |
| Special items | 0 | 10 | . | 0 | 9 | . |
| EBIT before special items | 230 | 202 | 13.8% | 483 | 443 | 9.0% |
| Investments including acquisitionsb | 908 | 674 | 34.7% | 1,468 | 1,057 | 38.9% |
| Segment cash flow | –406 | 31 | . | –962 | –156 | –517.5% |
| Assets (June 30) | 13,034 | 10,750 | 21.2% | 13,034 | 10,750 | 21.2% |
| Research and development expenses | 20 | 22 | –9.2% | 42 | 45 | –7.3% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data Q2/H1 — Materials
| Q2 | H1 | |||||
Million € |
2024 | 2023 | +/- | 2024 | 2023 | +/- |
| Sales to third parties | 3,416 | 3,609 | –5.3% | 6,857 | 7,453 | –8.0% |
of which Performance Materials |
1,740 | 1,843 | –5.6% | 3,499 | 3,793 | –7.8% |
Monomers |
1,675 | 1,765 | –5.1% | 3,358 | 3,659 | –8.2% |
EBITDA before special items |
448 | 462 | –3.2% | 956 | 910 | 5.0 % |
| EBITDA |
429 | 425 | 0.9% | 978 | 876 | 11.7% |
| EBITDA margin before special items (%) |
13.1 | 12.8 | − | 13.9 | 12.2 | − |
| Depreciation and amortizationa | 208 | 197 | 5.7% | 412 | 402 | 2.4% |
| Income from operations (EBIT) | 221 | 228 | –3.2% | 567 | 474 | 19.5% |
| Special items | –19 | –36 | 47.6% | 15 | –33 | . |
| EBIT before special items | 240 | 265 | –9.3% | 551 | 507 | 8.6% |
| Investments including acquisitionsb | 220 | 223 | –1.3% | 512 | 420 | 21.9% |
| Segment cash flow | 137 | 573 | –76.2% | 222 | 684 | –67.6% |
| Assets (June 30) | 10,386 | 10,499 | –1.1% | 10,386 | 10,499 | –1.1% |
| Research and development expenses | 45 | 46 | –2.8% | 91 | 94 | –3.1% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data Q2/H1 — Industrial Solutions
| Q2 | H1 | |||||
Million € |
2024 | 2023 | +/- | 2024 | 2023 | +/- |
| Sales to third parties | 2,147 |
2,050 |
4.8% |
4,204 |
4,193 |
0.3% |
of which Dispersions & Resins |
1,354 |
1,266 |
6.9% |
2,629 |
2,574 |
2.1% |
Performance Chemicals |
794 |
783 |
1.4% |
1,575 |
1,618 |
–2.7% |
EBITDA before special items |
320 |
207 |
54.3% |
652 |
507 |
28.5% |
| EBITDA |
320 |
278 |
15.0% |
650 |
570 |
14.1% |
| EBITDA margin before special items (%) |
14.9 |
10.1 |
− |
15.5 |
12.1 |
− |
| Depreciation and amortizationa | 86 |
83 |
3.0% |
170 |
178 |
–4.5% |
| Income from operations (EBIT) | 234 |
195 |
20.1% |
480 |
392 |
22.6% |
| Special items | 0 |
71 |
. |
–2 |
52 |
. |
| EBIT before special items | 234 |
124 |
88.7% |
482 |
340 |
41.6% |
| Investments including acquisitionsb | 56 |
69 |
–18.4% |
104 |
122 |
–15.0% |
| Segment cash flow | 150 |
414 |
–63.8% |
209 |
562 |
–62.8% |
| Assets (June 30) | 5,986 |
6,046 |
–1.0% |
5,986 |
6,046 |
–1.0% |
| Research and development expenses | 35 |
39 |
–11.8% |
71 |
80 |
–11.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data Q2/H1 — Surface Technologies
| Q2 | H1 | |||||
Million € |
2024 | 2023 | +/- | 2024 | 2023 | +/- |
| Sales to third parties | 3,235 |
4,226 |
–23.4% | 6,583 |
8,804 |
–25.2% |
of which Catalysts |
2,163 |
3,099 |
–30.2% |
4,478 |
6,638 |
–32.5% |
Coatings |
1,072 |
1,127 |
–4.9% |
2,105 |
2,166 |
–2.8% |
EBITDA before special items |
366 |
374 |
–2.1% |
722 |
776 |
–7.0% |
| EBITDA |
320 |
334 |
–4.2% |
647 |
703 |
–8.0% |
| EBITDA margin before special items (%) |
11.3 |
8.8 |
− |
11.0 |
8.8 |
− |
| Depreciation and amortizationa | 148 |
144 |
3.0% |
294 |
283 |
3.6% |
| Income from operations (EBIT) | 171 |
190 |
–9.7% |
353 |
420 |
–15.9% |
| Special items | –46 |
–40 |
–14.5% |
–75 |
–74 |
–2.0% |
| EBIT before special items | 218 |
230 |
–5.5% |
428 |
494 |
–13.2% |
| Investments including acquisitionsb | 109 |
130 |
–15.7% |
203 |
232 |
–12.7% |
| Segment cash flow | 190 |
427 |
–55.5% |
482 |
734 |
–34.3% |
| Assets (June 30) | 12,552 |
13,552 |
–7.4% |
12,552 |
13,552 |
–7.4% |
| Research and development expenses | 81 |
77 |
6.2% |
164 |
159 |
3.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data Q2/H1 — Nutrition & Care
| Q2 | H1 | |||||
Million € |
2024 | 2023 | +/- | 2024 | 2023 | +/- |
| Sales to third parties | 1,667 |
1,712 |
–2.7% |
3,396 |
3,538 |
–4.0% |
of which Care Chemicals |
1,164 |
1,175 |
–0.9% |
2,381 |
2,475 |
–3.8% |
Nutrition & Health |
503 |
538 |
–6.5% |
1,015 |
1,063 |
–4.6% |
EBITDA before special items |
183 |
140 |
31.1% |
445 |
331 |
34.4% |
| EBITDA |
195 |
168 |
16.0% |
456 |
358 |
27.2% |
| EBITDA margin before special items (%) |
11.0 |
8.2 |
− |
13.1 |
9.4 |
− |
| Depreciation and amortizationa | 175 |
107 |
63.4% |
306 |
217 |
41.0% |
| Income from operations (EBIT) | 20 |
61 |
–67.2% |
150 |
141 |
6.0% |
| Special items | –35 |
28 |
. |
–36 |
27 |
. |
| EBIT before special items | 54 |
33 |
67.4% |
186 |
114 |
62.5% |
| Investments including acquisitionsb | 189 |
180 |
5.1% |
327 |
323 |
1.2% |
| Segment cash flow | 19 |
186 |
–90.0% |
–45 |
189 |
. |
| Assets (June 30) | 7,775 |
7,832 |
–0.7% |
7,775 |
7,832 |
–0.7% |
| Research and development expenses | 35 |
40 |
–11.3% |
74 |
79 |
–6.5% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data Q2/H1 — Agricultural Solutions
| Q2 | H1 | |||||
Million € |
2024 | 2023 | +/- | 2024 | 2023 | +/- |
| Sales to third parties | 1,937 |
2,231 |
–13.2% |
5,415 |
6,122 |
–11.5% |
of which Fungicides |
594 |
660 |
–9.9% |
1,655 |
1,869 |
–11.5% |
Herbicides |
720 |
863 |
–16.7% |
1,640 |
2,085 |
–21.3% |
Insecticides |
243 |
220 |
10.2% |
520 |
533 |
–2.4% |
Seed Treatment |
119 |
132 |
–9.4% |
258 |
298 |
–13.3% |
Seeds & Traits |
261 |
355 |
–26.6% |
1,342 |
1,337 |
0.4% |
| EBITDA before special items | 135 |
392 |
–65.7% |
1,496 |
1,824 |
–18.0% |
| EBITDA | 123 |
388 |
–68.4% |
1,481 |
1,821 |
–18.7% |
| EBITDA margin before special items (%) | 6.9 |
17.6 |
− |
27.6 |
29.8 |
− |
| Depreciation and amortizationa | 168 |
179 |
–6.4% |
333 |
352 |
–5.1% |
| Income from operations (EBIT) | –45 |
208 |
. |
1,148 |
1,469 |
–21.9% |
| Special items | –14 |
–5 |
–187.2% |
–17 |
–3 |
–415.8% |
| EBIT before special items | –31 |
213 |
. |
1,165 |
1,473 |
–20.9% |
| Investments including acquisitionsb | 72 |
72 |
0.7% |
119 |
162 |
–26.5% |
| Segment cash flow |
1,005 |
1,079 |
–6.8% |
291 |
321 |
–9.4% |
| Assets (June 30) | 17,116 |
18,153 |
–5.7% |
17,116 |
18,153 |
–5.7% |
| Research and development expenses | 249 |
222 |
12.1% |
451 |
447 |
1.0% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Segment data Q2/H1 — Other
| Q2 | H1 | |||||
| Million € | 2024 | 2023 | +/- |
2024 | 2023 | +/- |
Sales to third parties |
870 |
799 |
8.9% |
1,607 |
1,676 |
–4.1% |
EBITDA before special items |
62 |
–24 |
. |
–498 |
–359 |
–38.7% |
of which costs for cross-divisional corporate research |
–49 |
–66 |
26.1% |
–102 |
–125 |
18.2% |
costs of corporate headquarters |
–58 |
–60 |
2.5% |
–118 |
–120 |
1.4% |
other businesses |
61 |
43 |
42.9% |
70 |
59 |
18.8% |
foreign currency results, hedging and other measurement effects |
17 |
12 |
44.0% |
–36 |
–26 |
–40.7% |
miscellaneous income and expenses |
91 |
48 |
90.1% |
–312 |
–148 |
–111.0% |
EBITDA |
–266 |
–84 |
–214.8% |
–890 |
–434 |
–105.0% |
| Depreciation and amortizationa | 49 |
37 |
33.6% |
85 |
75 |
14.0% |
| Income from operations (EBIT) | –315 |
–121 |
–159.9% |
–975 |
–509 |
–91.7% |
| Special items | –339 |
–61 |
–455.3% |
–403 |
–75 |
–435.8% |
EBIT before special items |
24 |
–60 |
. |
–572 |
–434 |
–32.0% |
| Investments including acquisitionsb | 82 |
41 |
99.1% |
110 |
72 |
53.7% |
| Assets (June 30)c | 15,598 |
16,672 |
–6.4% |
15,598 |
16,672 |
–6.4% |
Research and development expenses |
59 |
70 |
–15.6% |
121 |
149 |
–19.2% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
c Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group
| Million € | Sales by location of company |
Sales by location of customer |
||||
Q2 |
2024 |
2023 |
+/– |
2024 |
2023 |
+/– |
Europe |
6,697 |
6,991 |
–4.2% |
6,335 |
6,567 |
–3.5% |
of which Germany |
2,838 |
2,891 |
–1.8% |
1,554 |
1,739 |
–10.6% |
North America |
4,365 |
4,905 |
–11.0% |
4,291 |
4,890 |
–12.2% |
| Asia Pacific | 4,065 |
4,351 |
–6.6% |
4,182 |
4,427 |
–5.5% |
of which Greater China |
2,276 |
2,404 |
–5.3% |
2,267 |
2,387 |
–5.1% |
South America, Africa, Middle East |
984 |
1,058 |
–7.0% |
1,303 |
1,422 |
–8.4% |
BASF Group |
16,111 |
17,305 |
–6.9% |
16,111 |
17,305 |
–6.9% |
| H1 | ||||||
| Europe | 14,107 |
15,591 |
–9.5% |
13,461 |
14,768 |
–8.8% |
of which Germany |
5,778 |
6,263 |
–7.7% |
3,236 |
3,742 |
–13.5% |
| North America | 9,740 |
10,838 |
–10.1% |
9,523 |
10,811 |
–11.9% |
| Asia Pacific | 7,895 |
8,806 |
–10.3% |
8,106 |
8,941 |
–9.3% |
of which Greater China |
4,378 |
4,713 |
–7.1% |
4,338 |
4,663 |
–7.0% |
| South America, Africa, Middle East | 1,922 |
2,062 |
–6.8% |
2,574 |
2,777 |
–7.3% |
| BASF Group | 33,664 |
37,297 |
–9.7% |
33,664 |
37,297 |
–9.7% |